'Safety pharmacology' presentation slideshows

How Do I Get Into Phase 1 Trials With My Compound?

How Do I Get Into Phase 1 Trials With My Compound?. Greg Ruppert Director, North American Sales May 9, 2013. Preface and Disclaimer.

542 views • 44 slides

CURRENT PHARMACOLOGY & TOXICOLOGY GUIDLINES FOR PHARMACEUTICAL INDUSTRY

CURRENT PHARMACOLOGY & TOXICOLOGY GUIDLINES FOR PHARMACEUTICAL INDUSTRY. By. Dr. Basavaraj K. Nanjwade M.Pharm., Ph.D Associate Professor Department of Pharmaceutics KLE University BELGAUM - 10. Objective of the Guidance.

622 views • 43 slides

Dosage Determination from Preclinical to Proof-of-Concept Trials, (Including Toxicology)

Dosage Determination from Preclinical to Proof-of-Concept Trials, (Including Toxicology). Charlie Taylor, PhD CpTaylor Consulting Chelsea, MI, USA. Choosing Doses for POC:. Preclinical and early studies that enable dose selection Reasons for drug failure in clinical phase 2-3

791 views • 23 slides

Medivir September 2007 Lunch presentation at SHB

Medivir September 2007 Lunch presentation at SHB. CEO Lars Adlersson VP Research Bertil Samuelsson CFO / IR Rein Piir. Business model. Structure:. Revenue streams:. Research & development of protease inhibitors. Upfronts & milestones. Royalties. Sales & marketing of

191 views • 18 slides

378 views • 17 slides

Strategic Planning Subcommittee Strategic Goals

Strategic Planning Subcommittee Strategic Goals. Subcommittee Members Alan Bass Rick Briscoe Kristy Bruse Derek Leishman Ian MacKenzie Hugo Vargas Rob Wallis* Jean-Pierre Valentin* Clarissa Wilson *new members. Strategic Planning Subcommittee Original Charge.

261 views • 7 slides

Strategic Planning Subcommittee Strategic Goals

Strategic Planning Subcommittee Strategic Goals. Subcommittee Members Alan Bass Rick Briscoe Kristy Bruse Derek Leishman Ian MacKenzie Hugo Vargas Rob Wallis* Jean-Pierre Valentin* Clarissa Wilson *new members. Strategic Planning Subcommittee Original Charge.

78 views • 7 slides